New Risk • Jun 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (CA$1.89m market cap, or US$1.35m). Minor Risk Share price has been volatile over the past 3 months (13% average weekly change). New Risk • Mar 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (CA$2.18m market cap, or US$1.59m). Minor Risk Share price has been volatile over the past 3 months (15% average weekly change). Reported Earnings • Jul 31
Full year 2025 earnings released: EPS: CA$0.021 (vs CA$0.079 loss in FY 2024) Full year 2025 results: EPS: CA$0.021 (up from CA$0.079 loss in FY 2024). Revenue: CA$39.9m (up 9.6% from FY 2024). Net income: CA$599.0k (up CA$2.78m from FY 2024). Profit margin: 1.5% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings. Reported Earnings • Apr 03
Full year 2025 earnings released: EPS: CA$0.019 (vs CA$0.073 loss in FY 2024) Full year 2025 results: EPS: CA$0.019 (up from CA$0.073 loss in FY 2024). Revenue: CA$40.2m (up 18% from FY 2024). Net income: CA$561.8k (up CA$2.55m from FY 2024). Profit margin: 1.4% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings. Reported Earnings • Dec 31
Third quarter 2025 earnings released: EPS: CA$0.016 (vs CA$0.02 loss in 3Q 2024) Third quarter 2025 results: EPS: CA$0.016 (up from CA$0.02 loss in 3Q 2024). Revenue: CA$10.3m (up 27% from 3Q 2024). Net income: CA$474.9k (up CA$1.02m from 3Q 2024). Profit margin: 4.6% (up from net loss in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings. Reported Earnings • Oct 01
Second quarter 2025 earnings released: EPS: CA$0.012 (vs CA$0.006 loss in 2Q 2024) Second quarter 2025 results: EPS: CA$0.012 (up from CA$0.006 loss in 2Q 2024). Revenue: CA$9.76m (up 18% from 2Q 2024). Net income: CA$341.2k (up CA$503.7k from 2Q 2024). Profit margin: 3.5% (up from net loss in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Reported Earnings • Jul 05
First quarter 2025 earnings released: CA$0.018 loss per share (vs CA$0.012 loss in 1Q 2024) First quarter 2025 results: CA$0.018 loss per share (further deteriorated from CA$0.012 loss in 1Q 2024). Revenue: CA$9.88m (up 31% from 1Q 2024). Net loss: CA$508.2k (loss widened 56% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Reported Earnings • Jun 04
Full year 2024 earnings released: CA$0.073 loss per share (vs CA$0.31 profit in FY 2023) Full year 2024 results: CA$0.073 loss per share (down from CA$0.31 profit in FY 2023). Revenue: CA$34.1m (up 31% from FY 2023). Net loss: CA$1.99m (down 126% from profit in FY 2023). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings. New Risk • Jun 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (CA$4.35m market cap, or US$3.19m). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (8.1% increase in shares outstanding). Ankündigung • Dec 21
Delota Corp. announced that it has received CAD 0.9 million in funding from Plaza Capital Advisors On December 19, 2023, Delota Corp. closed the transaction. The company issued 900 debenture units to subscribers at a price of CAD 1,000 per debenture unit for the gross proceeds of CAD 900,000. Each debenture unit consisted of CAD 1,000 principal senior secured convertible debenture; and 10,000 common share purchase warrants exercisable for 10,000 common shares in the company. The debentures mature 18 months from the date of issuance and bear interest at a rate of 1% per month, beginning on the date of issuance and payable in cash on the last day of each calendar month. The principal sum of the debentures, or any portion thereof, and any accrued but unpaid interest may be converted into shares at a conversion price of CAD 0.10 per share, subject to adjustment conditional upon compliance with the polices of the Canadian Securities Exchange. Each warrant entitles the holder thereof to acquire one additional share at a price of CAD 0.15 per warrant share, subject to adjustment conditional upon compliance with the polices of the Canadian Securities Exchange, for a period of 36 months from the date of issuance. Certain debentures and all warrants issued pursuant to the offering are subject to a statutory hold period of four months and one day from the date of issuance thereof in accordance with applicable securities laws. In connection with the offering, the company paid the lead investor a closing fee of CAD 26,000 plus applicable taxes, equal to 4% of the gross proceeds arising from orders received from the lead investor group in the offering, and reimbursed the lead investor for reasonable and documented out-of-pocket expenses incurred in connection with the offering. Ankündigung • Dec 06
Delota Corp. announced that it expects to receive CAD 0.9 million in funding Delota Corp. announced a non-brokered private placement of 900 senior secured convertible debentures at a price of CAD 1,000 per debenture unit for aggregate gross proceeds of up to CAD 900,000 on December 5, 2023. The transaction was led by Plaza Capital Advisors. Each debenture unit will consist of a CAD 1,000 principal senior secured convertible debenture and 10,000 common share purchase warrants, exercisable for 10,000 common shares. The debentures will mature on the date that is 18 months from the date of issuance and shall bear interest at a rate of 1% per month, beginning on the date of issuance and payable in cash on the last day of each calendar month. The principal sum of the debentures, or any portion thereof, and any accrued but unpaid interest, may be converted into shares at a conversion price of CAD 0.10 per share, subject to adjustment conditional upon compliance with the polices of the Canadian Securities Exchange. Each warrant shall entitle the holder to acquire one additional share at a price of CAD 0.15 per warrant share, subject to adjustment conditional upon compliance with the polices of the CSE, for a period of 36 months from the date of issuance. All debentures and warrants issued pursuant to the offering will be subject to a statutory hold period of four months and one day from the date of issuance thereof. The company expects the offering to be completed in the week of December 11, 2023. The company will pay the lead investor a closing fee in connection with the offering comprised 4% of the gross proceeds arising from orders received from the lead investor group in the offering. The company has also agreed to reimburse the lead investor for reasonable and documented out-of-pocket expenses incurred in connection with the offering in the amount of up to CAD 30,000 plus applicable taxes and disbursements. Reported Earnings • Oct 01
Second quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0.003 loss in 2Q 2023) Second quarter 2024 results: CA$0.006 loss per share (further deteriorated from CA$0.003 loss in 2Q 2023). Revenue: CA$8.30m (up 28% from 2Q 2023). Net loss: CA$162.5k (loss widened 142% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. New Risk • Jul 23
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (22% average weekly change). Market cap is less than US$10m (CA$2.47m market cap, or US$1.87m). Minor Risk Shareholders have been diluted in the past year (2.4% increase in shares outstanding). Reported Earnings • Jul 01
First quarter 2024 earnings released: CA$0.012 loss per share (vs CA$0.42 profit in 1Q 2023) First quarter 2024 results: CA$0.012 loss per share (down from CA$0.42 profit in 1Q 2023). Revenue: CA$7.53m (up 30% from 1Q 2023). Net loss: CA$324.6k (down 104% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has fallen by 34% per year, which means it is significantly lagging earnings. Reported Earnings • Jun 02
Full year 2023 earnings released: EPS: CA$0.31 (vs CA$0.65 loss in FY 2022) Full year 2023 results: EPS: CA$0.31 (up from CA$0.65 loss in FY 2022). Revenue: CA$25.9m (up 47% from FY 2022). Net income: CA$7.67m (up CA$16.5m from FY 2022). Profit margin: 30% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. Reported Earnings • Jan 01
Third quarter 2023 earnings released: EPS: CA$0 (vs CA$0.03 loss in 3Q 2022) Third quarter 2023 results: EPS: CA$0 (improved from CA$0.03 loss in 3Q 2022). Revenue: CA$6.76m (up 26% from 3Q 2022). Net loss: CA$4.5k (loss narrowed 99% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Steven Glaser was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 30
Second quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.055 loss in 2Q 2022) Second quarter 2023 results: CA$0.003 loss per share (improved from CA$0.055 loss in 2Q 2022). Revenue: CA$6.48m (up 37% from 2Q 2022). Net loss: CA$67.3k (loss narrowed 92% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. Reported Earnings • Jul 01
First quarter 2023 earnings released: EPS: CA$0.42 (vs CA$0.019 loss in 1Q 2022) First quarter 2023 results: EPS: CA$0.42 (up from CA$0.019 loss in 1Q 2022). Revenue: CA$5.79m (up 186% from 1Q 2022). Net income: CA$7.94m (up CA$8.16m from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Reported Earnings • Jun 01
Full year 2022 earnings released: CA$0.65 loss per share (vs CA$0.15 loss in FY 2021) Full year 2022 results: CA$0.65 loss per share (down from CA$0.15 loss in FY 2021). Revenue: CA$17.7m (up CA$16.4m from FY 2021). Net loss: CA$8.84m (loss widened CA$7.54m from FY 2021). Board Change • Apr 27
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Executive Chairman Mark Pelchovitz is the most experienced director on the board, commencing their role in 2019. Independent Director Steven Glaser was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Dec 31
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: CA$0.03 loss per share (down from CA$0.017 loss in 3Q 2021). Revenue: CA$5.35m (up CA$4.85m from 3Q 2021). Net loss: CA$451.7k (loss widened 198% from 3Q 2021). Revenue was in line with analyst estimates. Reported Earnings • Oct 01
Second quarter 2022 earnings released: CA$0.055 loss per share (vs CA$0.046 loss in 2Q 2021) The company reported a solid second quarter result with improved revenues and control over costs, although losses increased. Second quarter 2022 results: Revenue: CA$4.73m (up CA$4.70m from 2Q 2021). Net loss: CA$801.3k (loss widened 105% from 2Q 2021). Reported Earnings • Jul 01
First quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.008 loss in 1Q 2021) The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2022 results: Revenue: CA$2.02m (up CA$1.95m from 1Q 2021). Net loss: CA$217.5k (loss narrowed 37% from 1Q 2021). Reported Earnings • Jun 03
Full year 2021 earnings released: CA$0.029 loss per share (vs CA$0.072 loss in FY 2020) The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: CA$1.28m (up 69% from FY 2020). Net loss: CA$1.31m (loss narrowed 40% from FY 2020). Ankündigung • Apr 03
Spyder Cannabis Inc. announced that it has received CAD 1 million in funding On April 1, 2021, Spyder Cannabis Inc. (TSXV:SPDR) closed the transaction. The company paid finder's fees of CAD 16,650 to Canaccord
Genuity Corp. and CAD 4,050 to PI Financial Corp. All Common Shares and Warrants issued pursuant to the Offering are subject to a statutory hold period of four months plus one day from the date of issuance in accordance with applicable securities legislation and TSXV policies. Ankündigung • Mar 02
Spyder Cannabis Inc., Annual General Meeting, Jul 12, 2021 Spyder Cannabis Inc., Annual General Meeting, Jul 12, 2021. Reported Earnings • Dec 24
Third quarter 2021 earnings released: CA$0.003 loss per share The company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2021 results: Revenue: CA$497.7k (up 194% from 3Q 2020). Net loss: CA$151.6k (loss narrowed 41% from 3Q 2020). Ankündigung • Nov 06
Spyder Cannabis Inc. Announces Resignation of Benjamin Leung as Independent Director Spyder Cannabis Inc. announced that Benjamin Leung, an independent director of the company has resigned. Ankündigung • Aug 23
Spyder Cannabis Inc. and The Green Spyder Inc. and Spyder Cannabis Subco Inc. Provides Update for Niagara Falls and Cannabis Dispensary and Calgary Cannabis Dispensary Spyder Cannabis Inc. and its wholly-owned associated applicants, The Green Spyder Inc. and Spyder Cannabis Subco Inc., provided the update that Niagara Falls and Cannabis Dispensary. The company also announced that its dispensary located at 6474 Lundy's Lane, passed its final inspection on July 27, 2020, and intends to open for business in the first week of August 2020. The company is also announced that its dispensary located at #140, 104 58 Avenue SE, was formally issued a Retail Cannabis Store License (No. 781144-1) and intends to open for business in August 2020.